Terumo Corporation ( TRUMY) - Stock Earnings
TRUMY Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026 AfterMarket | — / — | — | — / — | — |
TRUMY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 291.0 million USD | 1.8 billion USD |
| 2025Q3 | 241.0 million USD | 1.9 billion USD |
| 2025Q4 | 212.2 million USD | 1.9 billion USD |
| 2026Q3 Est. | — | — |
TRUMY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 672.5 million USD | 6.2 billion USD |
| 2024 | 702.6 million USD | 6.1 billion USD |
| 2025 | 783.2 million USD | 6.9 billion USD |
| 2026 Est. | — | — |
TRUMY
Price: $13.76
52 week price:
Dividend Yield: 1.30%
Payout Ratio Range:
Earnings Per Share: 0.58 USD
P/E Ratio: 25.59
Exchange: PNK
Sector: Healthcare
Industry: Medical Instruments & Supplies
Market Capitalization: 20.2 billion